Elizabeth Shrieves

Elizabeth Shrieves is a patent litigator whose practice spans a range of complex technology disputes, with a particular focus on medical devices. Her experience, as evidenced by tracked cases, includes litigation involving systems and methods for collecting plasma, such as those for Haemonetics Corporation. Her broader technical expertise, detailed in firm profiles, extends to software and applications, network security products, electrical hardware, telecommunications, semiconductors, and automotive engines.

In her litigation practice, Ms. Shrieves has experience representing both plaintiffs and defendants. While her tracked case appearances show a majority on the plaintiff side (4 out of 6), particularly for Haemonetics Corporation, her firm profile indicates a balanced practice encompassing both plaintiff and defense work from pre-suit investigation through appeal.

Ms. Shrieves is an associate in the Litigation Department and a member of the Intellectual Property and Patent Law groups at Proskauer Rose LLP, where she has been involved in the majority of her tracked patent litigation matters. She also has one tracked appearance with Cooley. Her notable engagements include representing Haemonetics Corporation in infringement actions, such as Haemonetics Corporation v. Terumo BCT, Inc. and multiple actions against Fresenius Kabi USA, LLC.

She is active in proceedings before the U.S. Patent and Trademark Office, specifically the Patent Trial and Appeal Board (PTAB), having drafted and participated in inter partes review petitions. Ms. Shrieves has also co-authored articles providing insights into PTAB strategy and discretionary denials in patent litigation. She is admitted to practice in the District of Columbia and Virginia. Ms. Shrieves earned her J.D., Magna Cum Laude, from George Mason University School of Law, and a B.A., Magna Cum Laude, from Wake Forest University.